Aromatase inhibition
Subtitle: then, now, and tomorrow
By: edited by M. Dowsett.
Contributors: Dowsett, M.
Series: The International congress, symposium, and seminar series -- v. 9
Publisher: Parthenon Pub. Group
Published: 1994
Place of publication: London; New York
Language: eng
Number of pages: 79
Subjects: Androstenedione -- analogs & derivatives -- congresses.; Androstenedione -- therapeutic use -- congresses.; Aromatase -- Inhibitors -- Therapeutic use.; Aromatase -- antagonists & inhibitors -- congresses.; Breast -- Cancer -- Treatment.; Breast Neoplasms -- drug therapy -- congresses.; Cancer -- Chemotherapy.; Enzyme inhibitors -- Therapeutic use.
Notes: "Presentations to a scientific review meeting sponsored by Ciba Pharmaceuticals held at Stratford upon Avon, 16 July 1993"--T.p. verso.

Includes bibliographical references and index.
Table of contents: title: 1. Medical endocrine therapy in the treatment of breast cancer / R.C. Coombes; title: 2. Development of formestane (Lentaron): historical perspective / R.C. Stein; title: 3. Formestane (Lentaron): clinical trials and adverse events data / A. Jeynes; title: 4. Importance of intratumoural aromatase, and its susceptibility to inhibitors / W.R. Miller; title: 5. Formestane (Lentaron): early clinical experience / C. Gallagher; title: 6. Future directions for the use of aromatase inhibitors / M. Dowsett; title: General discussion.